1. Home
  2. RTO vs HOLX Comparison

RTO vs HOLX Comparison

Compare RTO & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rentokil Initial plc

RTO

Rentokil Initial plc

N/A

Current Price

$33.24

Market Cap

15.4B

ML Signal

N/A

Logo Hologic Inc.

HOLX

Hologic Inc.

N/A

Current Price

$75.40

Market Cap

16.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RTO
HOLX
Founded
1925
1985
Country
United Kingdom
United States
Employees
65632
N/A
Industry
Business Services
Medical Electronics
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.4B
16.6B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
RTO
HOLX
Price
$33.24
$75.40
Analyst Decision
Buy
Hold
Analyst Count
3
13
Target Price
$35.00
$77.89
AVG Volume (30 Days)
1.5M
2.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.66%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.79
Revenue
N/A
$4,100,500,000.00
Revenue This Year
$17.39
$4.74
Revenue Next Year
$6.25
$5.03
P/E Ratio
$222.16
$95.46
Revenue Growth
N/A
1.74
52 Week Low
$19.60
$51.90
52 Week High
$33.46
$75.75

Technical Indicators

Market Signals
Indicator
RTO
HOLX
Relative Strength Index (RSI) 60.34 53.87
Support Level $30.95 $75.20
Resistance Level N/A N/A
Average True Range (ATR) 0.60 0.19
MACD 0.20 -0.01
Stochastic Oscillator 95.91 37.27

Price Performance

Historical Comparison
RTO
HOLX

About RTO Rentokil Initial plc

Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in 89 countries, with its largest operations in the United States following the acquisition of Terminix. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Share on Social Networks: